Clinical Trial Update: OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects [Phase 3]

View source ↗

Summary

This document reports the completion of Phase 3 trials of OPC-1085EL for primary open-angle glaucoma and ocular hypertension in Chinese subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• OPC-1085EL

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Open Angle Glaucoma or Ocular Hypertension | Phase 3 | Status: COMPLETED